US Patent Issued to OCULAR THERAPEUTIX on Oct. 28 for "Ocular implant containing a tyrosine kinase inhibitor" (Massachusetts, Washington Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,724, issued on Oct. 28, was assigned to OCULAR THERAPEUTIX INC. (Bedford, Mass.).

"Ocular implant containing a tyrosine kinase inhibitor" was invented by Charles D. Blizzard (Bedford, Mass.), Erica Kahn (Bedford, Mass.), Peter Jarrett (Bedford, Mass.), Rabia Gurses-Ozden (Bedford, Mass.), Rami El-Hayek (Bedford, Mass.), Elizabeth Braun (Bedford, Mass.), Joseph Iacona (Bedford, Mass.), Chintan Patel (Bedford, Mass.), Mark Ransbottom (Bedford, Mass.), Olivia Sherman (Bedford, Mass.) and William Isom (Bedford, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a sustained release biodegradable ocular implant containing axitin...